Who are Ephedrine, bolus's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): epinephrine perfusion, Normal saline with epinephrine, Low-dose epinephrine, cardiac output changes with "ephedrine", Ephedrine-S, Epinephrine (Adrenaline).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ephedrine-bolus.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Ephedrine, bolus — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ephedrine, bolus (Ephedrine, bolus) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sympathomimetic amine; adrenergic agonist. Area: Cardiovascular; Respiratory.

marketed Sympathomimetic amine; adrenergic agonist Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors Cardiovascular; Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Ephedrine, bolus (Ephedrine, bolus) — University of Parma. Ephedrine is a sympathomimetic amine that stimulates alpha and beta adrenergic receptors to increase heart rate, blood pressure, and bronchial airway dilation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Ephedrine, bolus TARGET	Ephedrine, bolus	University of Parma	marketed	Sympathomimetic amine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
epinephrine perfusion	epinephrine perfusion	Central Hospital, Nancy, France	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Normal saline with epinephrine	Normal saline with epinephrine	West Penn Allegheny Health System	marketed	Sympathomimetic amine / Vasopressor	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Low-dose epinephrine	Low-dose epinephrine	Icahn School of Medicine at Mount Sinai	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
cardiac output changes with "ephedrine"	cardiac output changes with "ephedrine"	University Tunis El Manar	marketed	Sympathomimetic amine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Ephedrine-S	Ephedrine-S	Dalian Municipal Central Hospital	marketed	Sympathomimetic amine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Epinephrine (Adrenaline)	Epinephrine (Adrenaline)	Aga Khan University	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors

Recent regulatory actions (last 90 days)

2026-03-19 — cardiac output changes with "ephedrine" · FDA · approved · US · University Tunis El Manar

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sympathomimetic amine; adrenergic agonist class)

Oslo University Hospital · 1 drug in this class
University Hospital, Ghent · 1 drug in this class
University of Parma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ephedrine, bolus — Competitive Intelligence Brief. https://druglandscape.com/ci/ephedrine-bolus. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing